Vietnam antirheumatic drugs market was valued at US$1,205.182 million in 2019. Increasing incidence of malaria is driving the demand for antirheumatic drugs in the country. Mushrooming number of people suffering from arthritis in Vietnam is another major factor that is spurring the demand for antirheumatic drugs in the country. In 2019, the University of Medical Center in Ho Chi Minh City reported the ever-increasing number of rheumatoid arthritis patients. With growing adoption of Western lifestyle and incidence of lifestyle-associated chronic diseases has further increased the prevalence of arthritis in the country. Moreover, ageing population is escalating in Vietnam which will further continue to propel the market growth of antirheumatic drugs in this country during the next five years. Growing Vietnam pharmaceutical industry is also supporting the market growth of antirheumatic drugs in the country. Positive changes in government policies are also boosting the growth of the country’s pharmaceutical sector, thus positively impacting the market growth of antirheumatic drugs. Increasing sale of OTC drugs as Vietnamese prefer to self-medicate and buy their drugs from private pharmacies is also fuelling the antirheumatic drugs market growth in this country.
Vietnam antirheumatic drugs market has been segmented based on the type of disease, type of molecule, and sales channel. By type of disease, the market has been segmented as osteoarthritis,rheumatoid arthritis, gout, lupus, and others. By type of molecule, the Vietnam antirheumatic drugs market has been classified into pharmaceuticals and biopharmaceuticals. The market segmentation has also been done by sales channel as prescription and over-the-counter (OTC).